Eplerenone and clarithromycin — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Clarithromycin can increase eplerenone exposure and hyperkalaemia risk
Eplerenone is affected by CYP3A4 inhibitors and potassium risk is clinically relevant. In this scenario, the pharmacist should prioritise safe supply, appropriate counselling and timely referral or clarification where needed. This is the single best answer because the other options would either delay assessment, ignore a clinically significant risk, or create an unsafe legal or professional outcome.
Reference: BNF